3D printing of five-in-one dose combination polypill with defined immediate and sustained release profiles.
TLDR
3D extrusion printing was used to manufacture a multi-active solid dosage form that showed the intended immediate and sustained release profiles based upon the active/excipient ratio used and demonstrates that complex medication regimes can be combined in a single personalised tablet.About:
This article is published in Journal of Controlled Release.The article was published on 2015-11-10 and is currently open access. It has received 405 citations till now. The article focuses on the topics: Polypill & Dissolution testing.read more
Citations
More filters
Journal ArticleDOI
3D printing in pharmaceutics: A new tool for designing customized drug delivery systems
Jonathan Goole,Karim Amighi +1 more
TL;DR: This paper aims to review the processes that can be used in pharmaceutics, including the parameters to be controlled, to give an overview on the pragmatic tools, which can beused for designing customized drug delivery systems using 3D printing.
Journal ArticleDOI
Recent progress in drug delivery
Chong Li,Jiancheng Wang,Yiguang Wang,Huile Gao,Gang Wei,Yongzhuo Huang,Haijun Yu,Yong Gan,Yongjun Wang,Lin Mei,Huabing Chen,Haiyan Hu,Zhiping Zhang,Yiguang Jin +13 more
TL;DR: This review provides a concise overview of current progress in this research area through its focus on the delivery strategies, construction techniques and specific examples.
Journal ArticleDOI
Emergence of 3D Printed Dosage Forms: Opportunities and Challenges
Mohamed Albed Alhnan,Tochukwu Chijioke Okwuosa,Muzna Sadia,Ka-Wai Wan,Waqar Ahmed,Basel Arafat +5 more
TL;DR: Various3D printing technologies such as stereolithographic, powder based, selective laser sintering, fused deposition modelling and semi-solid extrusion 3D printing are presented and their advantages particularly with adaptability in the pharmaceutical field have been highlighted.
Journal ArticleDOI
3D Printing in Pharmaceutical and Medical Applications – Recent Achievements and Challenges
TL;DR: This review summarizes the newest achievements and challenges of additive manufacturing in the field of pharmaceutical and biomedical research that have been published since 2015.
Journal ArticleDOI
Current and emerging applications of 3D printing in medicine.
Chya Yan Liaw,Murat Guvendiren +1 more
TL;DR: The goal is to discuss the current and emerging applications of 3D printing in medicine, a brief summary on additive manufacturing technologies and available printable materials, and the technological and regulatory barriers that are slowing down the full implementation of 3d printing in the medical field.
References
More filters
Journal ArticleDOI
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
Scott M. Grundy,David W. Bilheimer,Alan Chait,Luther T. Clark,Margo A. Denke,Richard J. Havel,William R. Hazzard,Stephen B. Hulley,Donald B. Hunninghake,Robert A. Kreisberg,Penny M. Kris-Etherton,James M. McKenney,Michael A. Newman,Ernst J. Schaefer,Burton E. Sobel,Carolyn Somelofski,Milton C. Weinstein,H. Bryan Brewer,James I. Cleeman,Karen A. Donato,Nancy D. Ernst,Jeffrey M. Hoeg,Basil M. Rifkind,Jacques E. Rossouw,Christopher T. Sempos,Joanne M. Gallivan,Maureen N. Harris,Laurie Quint-Adler +27 more
TL;DR: Dairy therapy remains the first line of treatment of high blood cholesterol, and drug therapy is reserved for patients who are considered to be at high risk for CHD, and the fundamental approach to treatment is comparable.
Journal ArticleDOI
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.
TL;DR: Throughout middle and old age, usual blood pressure is strongly and directly related to vascular (and overall) mortality, without any evidence of a threshold down to at least 115/75 mm Hg.
Journal Article
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
Anders G. Olsson,Jjv McMurray,Gudmundur Thorgeirsson,C Spaulding,J Slattery,Kalevi Pyörälä,Ole Faergeman,RA Wright,Kåre Berg,Lars Wilhelmsen,Terje R. Pedersen,Tatu A. Miettinen,Harvey D. White,John Kjekshus,Michael Gnant +14 more
Journal ArticleDOI
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
TL;DR: Aspirin (or another oral antiplatelet drug) is protective in most types of patient at increased risk of occlusive vascular events, including those with an acute myocardial infarction or ischaemic stroke, unstable or stable angina, previous myocardian infarctions, stroke or cerebral ischaemia, peripheral arterial disease, or atrial fibrillation.
Journal ArticleDOI
Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis.
TL;DR: Statins can lower LDL cholesterol concentration by an average of 1.8 mmol/l which reduces the risk of IHD events by about 60% and stroke by 17% and is corroborated by results from the nine cohort studies.